You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 27 No. 1, July 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Variation in Response to Anticonvulsants in a Group of Epileptic Patients

Richard D. Travers, MD; Edward H. Reynolds, MD; Brian B. Gallagher, MD, PhD

Arch Neurol. 1972;27(1):29-33.


Abstract

In 118 adult epileptic patients with grand mal and/or temporal-limbic epilepsy, the mean serum concentration of diphenylhydantoin, phenobarbital, primidone, and phenobarbital derived from primidone increased directly with mean dose administered. With a given dose of each drug, wide individual variation in serum concentration existed. Women consistently received a larger dose of each medication per unit of body weight than men, yet women uniformly obtained lower serum concentrations of each drug. Those subjects with more frequent and/or more poorly controlled seizures received the largest doses of diphenylhydantoin and phenobarbital and obtained higher serum concentrations of these drugs than those patients with less frequent and better controlled seizures. Men and women were unevenly distributed with regard to seizure frequency and control. The heterogenous nature of a population of seizure patients was emphasized.



Author Affiliations

New Haven, Conn

From the Department of Neurology, Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication Jan 27, 1972.

Read before the annual meeting of the American Neurological Association, Washington, DC, April 28, 1971.

Reprint requests to Department of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, Conn 06510 (Dr. Gallagher).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Carbamazepine Plasma Concentration: Relationship to Cognitive Impairment
O'Dougherty et al.
Arch Neurol 1987;44:863-867.
ABSTRACT  

Usefulness of Blood Levels of Antiepileptic Drugs
Kutt and Penry
Arch Neurol 1974;31:283-288.
ABSTRACT  

Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma Levels: A Prospective Three-Year Study in Ambulant Patients With Generalized Epileptic Seizures
Lund
Arch Neurol 1974;31:289-294.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.